167 related articles for article (PubMed ID: 32547107)
21. LncRNA TMPO-AS1 serves as a sponge for miR-4731-5p modulating breast cancer progression through FOXM1.
Wang Y; Ma J; Li R; Gao X; Wang H; Jiang G
Am J Transl Res; 2021; 13(10):11094-11106. PubMed ID: 34786045
[TBL] [Abstract][Full Text] [Related]
22. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
[TBL] [Abstract][Full Text] [Related]
23. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
24. Long Non-Coding RNA TTN-AS1 Promotes the Proliferation and Invasion of Colorectal Cancer Cells by Activating miR-497-Mediated PI3K/Akt/mTOR Signaling.
Cui Z; Han B; Wang X; Li Z; Wang J; Lv Y
Onco Targets Ther; 2019; 12():11531-11539. PubMed ID: 31920341
[TBL] [Abstract][Full Text] [Related]
25. lncRNA TTN-AS1 facilitates proliferation, invasion, and epithelial-mesenchymal transition of breast cancer cells by regulating miR-139-5p/ZEB1 axis.
Fang J; Huang C; Ke J; Li J; Zhang W; Xue H; Chen J
J Cell Biochem; 2020 Dec; 121(12):4772-4784. PubMed ID: 32100921
[TBL] [Abstract][Full Text] [Related]
26. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
27. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
[TBL] [Abstract][Full Text] [Related]
28. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
Peng X; Yan J; Cheng F
Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
Fu A; Yu Z; Zhang E; Song J
Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
[TBL] [Abstract][Full Text] [Related]
31. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
[TBL] [Abstract][Full Text] [Related]
32. LncRNA TTN-AS1 confers tamoxifen resistance in breast cancer via sponging miR-107 to modulate PI3K/AKT signaling pathway.
Fang J; Li K; Huang C; Xue H; Ni Q
Am J Transl Res; 2022; 14(4):2267-2279. PubMed ID: 35559394
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
34. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
35. LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p.
Dong MM; Peng SJ; Yuan YN; Luo HP
Neoplasma; 2019 Jul; 66(4):564-575. PubMed ID: 30943745
[TBL] [Abstract][Full Text] [Related]
36. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
Zhou B; Guo H; Tang J
Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
[TBL] [Abstract][Full Text] [Related]
37. Silencing of the Long Non-Coding RNA TTN-AS1 Attenuates the Malignant Progression of Osteosarcoma Cells by Regulating the miR-16-1-3p/TFAP4 Axis.
Meng X; Zhang Z; Chen L; Wang X; Zhang Q; Liu S
Front Oncol; 2021; 11():652835. PubMed ID: 34141611
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis.
Fu SW; Zhang Y; Li S; Shi ZY; Zhao J; He QL
Cancer Cell Int; 2020; 20():415. PubMed ID: 32863773
[TBL] [Abstract][Full Text] [Related]
39. LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis.
Lin Z; Li Y; Shao R; Hu Y; Gao H
World J Surg Oncol; 2021 Jun; 19(1):163. PubMed ID: 34090483
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
